HRMY Earnings Harmony Biosciences Holdings, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–28 of 28
| Q2 2026 | 2026-06-30 | 1.84 | 2026-08-04 | 10-Q |
| Q1 2026 | 2026-03-31 | 0.55 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | 2.71 | 2026-02-24 | 10-K |
| Q3 2025 | 2025-09-30 | 2.32 | 2025-11-04 | 10-Q |
| Q2 2026 | 2025-06-30 | 1.46 | 2026-08-04 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.78 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | 2.51 | 2026-02-24 | 10-K |
| Q3 2025 | 2024-09-30 | 1.66 | 2025-11-04 | 10-Q |
| Q2 2025 | 2024-06-30 | 0.87 | 2025-08-05 | 10-Q |
| Q1 2025 | 2024-03-31 | 0.67 | 2025-05-06 | 10-Q |
| FY 2025 | 2023-12-31 | 2.13 | 2026-02-24 | 10-K |
| Q3 2024 | 2023-09-30 | 1.68 | 2024-10-29 | 10-Q |
| Q2 2024 | 2023-06-30 | 1.05 | 2024-08-06 | 10-Q |
| Q1 2024 | 2023-03-31 | 0.48 | 2024-04-30 | 10-Q |
| FY 2024 | 2022-12-31 | 2.97 | 2025-02-25 | 10-K |
| Q3 2023 | 2022-09-30 | 2.18 | 2023-10-31 | 10-Q |
| Q2 2023 | 2022-06-30 | 0.74 | 2023-08-01 | 10-Q |
| Q1 2023 | 2022-03-31 | 0.35 | 2023-05-02 | 10-Q |
| FY 2023 | 2021-12-31 | 0.58 | 2024-02-22 | 10-K |
| Q3 2022 | 2021-09-30 | 0.20 | 2022-11-01 | 10-Q |
| Q2 2022 | 2021-06-30 | 0.37 | 2022-08-02 | 10-Q |
| Q1 2022 | 2021-03-31 | 0.13 | 2022-05-03 | 10-Q |
| FY 2022 | 2020-12-31 | -2.48 | 2023-02-21 | 10-K |
| Q3 2021 | 2020-09-30 | -4.15 | 2021-11-09 | 10-Q |
| Q2 2021 | 2020-06-30 | -7.63 | 2021-08-10 | 10-Q |
| Q1 2021 | 2020-03-31 | -6.30 | 2021-05-11 | 10-Q |
| FY 2021 | 2019-12-31 | -24.07 | 2022-02-28 | 10-K |
| Q3 2020 | 2019-09-30 | -18.15 | 2020-11-12 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.